Bioequivalence Study of Oseltamivir Phosphate Capsules in Human

Language
- 中文版
- English

关于先锋

Company Profile

Research cooperation

Research trends

Research strength

Bioequivalence Study of Oseltamivir Phosphate Capsules in Human

Release time:

2023-07-12

Indications:

For the treatment of influenza A and B in adults and children aged 1 and over (oseltamivir phosphate can effectively treat influenza A and B, but there are not many clinical application data for influenza B) . Patients should use it within 48 hours of the first onset of symptoms. (2) For the prevention of influenza A and B in adults and adolescents aged 13 and over.

Test group: